
A new pan-European women’s health survey from the European Migraine & Headache Alliance reveals a systemic blind spot: most women affected by migraine are of working age yet face delayed diagnosis and fragmented care.
The evidence highlights the poorly understood link between migraine and hormonal transitions—menstruation, perimenopause and menopause—compounded by stigma.
This live studio discussion explores where the EU is underperforming on research and treatment access, and sets out practical implications for employers, health systems and policymakers seeking to close the gender health gap and modernise care pathways across Europe.














